Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 203

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Predicting MCI outcome with clinically available MRI and CSF biomarkers

Open access
Heister, D., Brewer, J.B., Magda, S., Blennow, K., McEvoy, L.K., For the Alzheimer's Disease Neuroimaging Initiative · 2011 · Neurology

Abstract

OBJECTIVE: To determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer disease (AD) in patients with mild cognitive impairment (MCI). METHODS: We stratified 192 MCI participants into positive and negative risk groups on the basis of 1) degree of learning impairment on the Rey Auditory Verbal Learning Test; 2) medial temporal atrophy, quantified from Food and Drug Administration-approved software for automated vMRI analysis; and 3) CSF biomarker levels(.) We also stratified participants based on combinations of risk factors. We computed Cox proportional hazards models, controlling for age, to assess 3-year risk of converting to AD as a function of risk group and used Kaplan-Meier analyses to determine median survival times. RESULTS: When risk factors were examined separately, individuals testing positive showed significantly higher risk of converting to AD than individuals testing negative (hazard ratios [HR] 1.8-4.1). The joint presence of any 2 risk factors substantially increased risk, with the combination of greater learning impairment and increased atrophy associated with highest risk (HR 29.0): 85% of patients with both risk factors converted to AD within 3 years, vs 5% of those with neither. The presence of medial temporal atrophy was associated with shortest median dementia-free survival (15 months). CONCLUSIONS: Incorporating quantitative assessment of learning ability along with vMRI or CSF biomarkers in the clinical workup of MCI can provide critical information on risk of imminent conversion to AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3182343314

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 22

  1. 10.1212/01.wnl.0000256697.20968.d7 · DOI · Paper page
  2. 10.1148/radiol.2511080924 · DOI · Paper page
  3. Mattsson N, Zetterberg H, Blennow K. Lessons from multicenter studies on CSF biomarkers for Alzheimer's disease. Int J Alzheimers Dis 2010;2010:610–613.
  4. 10.1212/WNL.0b013e3181af79fb · DOI · Paper page
  5. 10.1007/s00401-011-0808-0 · DOI · Paper page
  6. 10.1016/j.neurobiolaging.2006.05.006 · DOI · Paper page
  7. 10.1093/brain/awq277 · DOI · Paper page
  8. 10.1159/000289814 · DOI
  9. Ewers M, Walsh C, Trojanowski JQ, et al.. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging Epub 2010 Dec 13.
  10. Zetterberg H, Mattsson N, Blennow K. Cerebrospinal fluid analysis should be considered in patients with cognitive problems. Int J Alzheimers Dis 2010;163065.
  11. 10.1155/2009/616581 · DOI
  12. 10.1007/s12603-009-0106-x · DOI
  13. 10.3174/ajnr.A1402 · DOI · Paper page
  14. 10.1097/WAD.0b013e318192e745 · DOI
  15. 10.1212/WNL.42.1.183 · DOI · Paper page
  16. 10.1373/clinchem.2004.039347 · DOI · Paper page
  17. 10.1373/clinchem.2006.081679 · DOI
  18. 10.1155/2009/609839 · DOI · Paper page
  19. 10.1523/JNEUROSCI.3785-09.2010 · DOI · Paper page
  20. 10.1001/archneurol.2009.272 · DOI · Paper page
  21. 10.1002/emmm.200900048 · DOI · Paper page
  22. 10.1038/nrd3115 · DOI · Paper page

Cited by

See all 203

Metadata

Authors
Heister, D., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., & Initiative, F. T. A. D. N.
Venue
Neurology
Published
2011-10-25
Volume
77
Issue
17
Pages
1619-1628
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2130126582
Cited by
203
References
19
FWCI
12.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting MCI outcome with clinically available MRI and CSF biomarkers. https://app.cochat.ai/papers/10.1212/wnl.0b013e3182343314
The paper
Heister, D., Brewer, J. B., Magda, S., Blennow, K., McEvoy, L. K., & Initiative, F. T. A. D. N. (2011). Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology. https://doi.org/10.1212/wnl.0b013e3182343314

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.